ADVANCED LYMPHOMA
Clinical trials for ADVANCED LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED LYMPHOMA trials appear
Sign up with your email to follow new studies for ADVANCED LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug AN4005 enters first human tests
Disease control Recruiting nowThis early-phase study tests a new drug called AN4005 in about 31 adults with advanced solid tumors or lymphoma that has not responded to standard treatments. The main goal is to find a safe dose and check for side effects. Participants receive the drug and are closely monitored …
Matched conditions: ADVANCED LYMPHOMA
Phase: PHASE1 • Sponsor: Adlai Nortye Biopharma Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 02:08 UTC
-
New drug TAK-243 targets cancer cells in early trial
Disease control Recruiting nowThis early-phase study tests the safety and best dose of TAK-243, a drug that targets a protein cancer cells need to grow. About 95 adults with advanced solid tumors or lymphoma that hasn't responded to standard treatments will take part. The goal is to find side effects and the …
Matched conditions: ADVANCED LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 02:04 UTC
-
New drug combo aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis study tests two experimental drugs, ZEN003694 and entinostat, in people with advanced solid tumors that have stopped responding to standard treatments. The goal is to find the safest dose and see if the combination can shrink tumors. The trial includes up to 49 participants,…
Matched conditions: ADVANCED LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
Cancer care at home: a game changer for patients?
Symptom relief Recruiting nowThis study compares giving cancer treatment at home versus in a clinic for people with advanced cancers. The goal is to see if home treatment reduces stress, financial burden, and improves the overall experience. About 220 participants will be randomly assigned to receive their t…
Matched conditions: ADVANCED LYMPHOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 14, 2026 12:04 UTC